Clinical Trial Update: Eradication of H. Pylori Infection With Moxifloxacin [Phase 3]

View source ↗

Summary

Phase 3 trial update on eradication of Helicobacter pylori infection using moxifloxacin has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Iyad Naeem Muhammad, PhD | Conditions: Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to | Phase 3 | Status: COMPLETED